We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 257 results
  1. Acute interstitial nephritis with podocyte foot-process effacement complicating Plasmodium falciparum infection

    Background

    Malarial acute renal failure (MARF) is a component of the severe malaria syndrome, and complicates 1–5% of malaria infections. This form of...

    Patrick J. Gleeson, John A. O’Regan, ... Donal Reddan in Malaria Journal
    Article Open access 01 March 2019
  2. Detrimental effects of hypoxia on glomerular podocytes

    Hypoxia-inducible factor1 (HIF1) plays a pivotal role in ensuring cells adapt to low-oxygen conditions. Depletion of oxygen, a co-substrate during...

    Ashish K. Singh, Lakshmi P. Kolligundla, ... Anil K. Pasupulati in Journal of Physiology and Biochemistry
    Article 09 April 2021
  3. Engulfment and Cell Motility Protein (ELMO)-1 as a Biomarker in Type II Diabetes

    Increasing prevalence of T2DM in parallel with increased prevalence of DN, which leading cause of ESRD and T2DM. Albuminuria as a standard biomarker...
    Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali in Biomarkers in Diabetes
    Reference work entry 2023
  4. IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease

    Podocyte apoptosis or loss is the pivotal pathological characteristic of diabetic kidney disease (DKD). Insulin-like growth factor-binding protein 2...

    **aochen Wang, Yifan Zhang, ... Quan Hong in Apoptosis
    Article 25 May 2024
  5. Histone modification in podocyte injury of diabetic nephropathy

    Diabetic nephropathy (DN), an important complication of diabetic microvascular disease, is one of the leading causes of end-stage renal disease...

    Simeng Wang, **nyu Zhang, ... Rong Wang in Journal of Molecular Medicine
    Article 30 August 2022
  6. Engulfment and Cell Motility Protein (ELMO)-1 as a Biomarker in Type II Diabetes

    Increasing prevalence of T2DM in parallel with increased prevalence of DN, which leading cause of ESRD and T2DM. Albuminuria as a standard biomarker...
    Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali in Biomarkers in Diabetes
    Living reference work entry 2022
  7. Capillary rarefaction: a missing link in renal and cardiovascular disease?

    Patients with chronic kidney disease (CKD) have an increased risk for cardiovascular morbidity and mortality. Capillary rarefaction may be both one...

    Floor M. E. G. Steegh, Anke A. Keijbeck, ... Carine J. Peutz-Kootstra in Angiogenesis
    Article 16 June 2023
  8. Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation

    To explore the role of Notch1 pathway in the pathogenesis of podocyte injury, and to provide novel strategy for podocyte repair in lupus nephritis...

    Dan Wu, Tingting Jiang, ... Lingyun Sun in Inflammation
    Article 12 December 2023
  9. The Critical Role of the Shroom Family Proteins in Morphogenesis, Organogenesis and Disease

    The Shroom (Shrm) family of actin-binding proteins has a unique and highly conserved Apx/Shrm Domain 2 (ASD2) motif. Shroom protein directs the...

    Wanling Liu, Lei **u, ... **g Wu in Phenomics
    Article 06 March 2024
  10. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity

    The activation of nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome has been reported to...

    Dandan Huang, Jason M. Kidd, ... Guangbi Li in Inflammation
    Article 21 July 2023
  11. Novel Pathogenic Mutation of P209L in TRPC6 Gene Causes Adult Focal Segmental Glomerulosclerosis

    Focal segmental glomerulosclerosis (FSGS) is a leading kidney disease, clinically associated with proteinuria and progressive renal failure. The...

    Tianxi Yu, Yongqiang Ji, ... Chunhua Lin in Biochemical Genetics
    Article 05 February 2024
  12. Novel pathogenic variants in CUBN uncouple proteinuria from renal function

    Background

    Proteinuria is an unfavorable clinical condition highly associated with a risk of renal and cardiovascular disease in chronic kidney...

    Chun Gan, **ndi Zhou, ... Qiu Li in Journal of Translational Medicine
    Article Open access 20 October 2022
  13. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway

    Sirtuins (Sirts) are a family of nicotinamide adenine dinucleotide-dependent protein deacetylases that share diverse cellular functions. Increasing...

    Hua Miao, Yan-ni Wang, ... Ying-yong Zhao in Acta Pharmacologica Sinica
    Article 28 August 2023
  14. Immune-mediated entities of (primary) focal segmental glomerulosclerosis

    Focal segmental glomerulosclerosis (FSGS) represents a glomerular scar formation downstream of various different mechanisms leading to podocytopathy...

    Fabian Braun, Inka Homeyer, ... Tobias B. Huber in Cell and Tissue Research
    Article Open access 27 April 2021
  15. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane

    Abstract

    Not only in kidney glomerular physiological function but also glomerular pathology especially in diabetic condition, glomerular podocytes...

    Takahiro Ishikawa, Minoru Takemoto, ... Koutaro Yokote in Journal of Molecular Medicine
    Article 23 February 2021
  16. Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis

    Background

    Focal and segmental glomerulosclerosis (FSGS) is a histological pathology that characterizes a wide spectrum of diseases. Many genes...

    Hafiz Muhammad Jafar Hussain, Yikai Cai, ... **gyuan **e in Human Genomics
    Article Open access 12 November 2022
  17. The glomerular filtration barrier: a structural target for novel kidney therapies

    Loss of normal kidney function affects more than 10% of the population and contributes to morbidity and mortality. Kidney diseases are currently...

    Ilse S. Daehn, Jeremy S. Duffield in Nature Reviews Drug Discovery
    Article 14 July 2021
  18. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity

    Panax notoginseng , a traditional Chinese medicine, exerts beneficial effect on diabetic kidney disease (DKD), but its mechanism is not well...

    Jia-yi He, Quan Hong, ... **ang-mei Chen in Acta Pharmacologica Sinica
    Article 22 November 2021
  19. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury

    Background

    It is widely acknowledged that cisplatin-induced nephrotoxicity hinders its efficacy during clinical therapy. Effective pharmaceutical...

    Qiming Gong, Tengfang Lai, ... Fahui Liu in Molecular Medicine
    Article Open access 24 October 2023
  20. Axon guidance molecules in immunometabolic diseases

    The global prevalence of metabolic diseases, such as obesity, diabetes, and atherosclerosis, is rapidly increasing and has now reached epidemic...

    Yoshimitsu Nakanishi, Su** Kang, Atsushi Kumanogoh in Inflammation and Regeneration
    Article Open access 19 January 2022
Did you find what you were looking for? Share feedback.